These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 354202)

  • 1. [Survival of 5-fluorouracil-treated stomach cancer patients in the far-advanced stages].
    Korman DB
    Vopr Onkol; 1978; 24(7):51-5. PubMed ID: 354202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival of patients with inoperable stomach cancer treated with 5-fluorouracil].
    Korman DB
    Vopr Onkol; 1976; 22(2):78-82. PubMed ID: 1274269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
    Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary results of the use of 5-fluoruracil to prevent recurrences and metastases following radical surgery for stomach cancer].
    Blokhina NG; Garin AM; Voznyĭ EK; Moroz LV; Karev NI
    Vestn Akad Med Nauk SSSR; 1972; 27(10):29-36. PubMed ID: 4641119
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effectiveness of arterial infusion chemotherapy in advanced and recurrent gastric cancer].
    Sato M; Terashima M; Takagane A; Saito K; Odaka Y; Oikawa K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2927-31. PubMed ID: 2782900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].
    Masuyama M; Taniguchi H; Takeuchi K; Miyata K; Koyama H; Tanaka H; Higashida T; Koishi Y; Mugitani T; Yamaguchi T
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2253-5. PubMed ID: 7944452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective randomized study in advanced stomach cancer. Comparison between combinations of 5-fluorouracil and carmustine without and with adriamycin].
    Queisser W; Schnitzler G; Heim ME; König H; Katz R; Fritze D; Herrmann R; Arnold H; Henss H; Trux F
    Dtsch Med Wochenschr; 1984 Jun; 109(25):976-80. PubMed ID: 6734453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
    Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
    Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
    Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of gastric cancer with concomitant liver metastases.
    Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
    Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
    Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrences after surgical treatment of early (pT1) cancer of the stomach: laws of development, extended lymphadenectomy in prophylaxis of recurrences].
    Skoropad VIu; Berdov BA
    Khirurgiia (Mosk); 2007; (1):43-8. PubMed ID: 17426689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity and survival in gastric cancer patients with microsatellite instability.
    Oki E; Kakeji Y; Zhao Y; Yoshida R; Ando K; Masuda T; Ohgaki K; Morita M; Maehara Y
    Ann Surg Oncol; 2009 Sep; 16(9):2510-5. PubMed ID: 19565284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
    Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
    Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?
    Böhner H; Zimmer T; Hopfenmüller W; Berger G; Buhr HJ
    Hepatogastroenterology; 2000; 47(35):1489-94. PubMed ID: 11100384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.